Harvey Jones called on artificial intelligence to help him decide where to invest this year's Stocks and Shares ISA allowance ...
AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...
Biosimilars have been on the market in Europe since 2007 but have had a larger impact on Amgen since 2019 as US exposure intensifies. Pressure on Prolia/Xgeva is coming in 2025. Amgen's pipeline had ...
On supercomputers and life sciences, listening to Treasury naysayers risks letting work and political capital slip away ...
Despite major advances in artificial intelligence (AI) research for healthcare, the deployment and adoption of AI technologies remain limited in clinical practice. This paper describes the FUTURE-AI ...